Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children's Oncology Group study

被引：3

作者：

Rheingold, Susan R. ^{[1
,2
]}

Bhojwani, Deepa ^{[3
,4
]}

Ji, Lingyun ^{[5
]}

Xu, Xinxin ^{[6
]}

Devidas, Meenakshi ^{[7
]}

Kairalla, John A. ^{[8
]}

Shago, Mary ^{[9
]}

Heerema, Nyla A. ^{[10
]}

Carroll, Andrew J. ^{[11
]}

Breidenbach, Heather ^{[12
]}

Borowitz, Michael ^{[13
]}

Wood, Brent L. ^{[14
]}

Angiolillo, Anne L. ^{[15
]}

Asselin, Barbara L. ^{[16
]}

Bowman, W. Paul ^{[17
]}

Brown, Patrick ^{[18
]}

Dreyer, ZoAnn E. ^{[19
]}

Dunsmore, Kimberly P. ^{[20
]}

Hilden, Joanne M. ^{[21
,22
]}

Larsen, Eric ^{[23
]}

Maloney, Kelly ^{[21
,22
]}

Matloub, Yousif ^{[24
]}

Mattano, Leonard A. ^{[25
]}

Winter, Stuart S. ^{[26
]}

Gore, Lia ^{[21
,22
]}

Winick, Naomi J. ^{[27
]}

Carroll, William L. ^{[28
]}

Hunger, Stephen P. ^{[1
,2
]}

Raetz, Elizabeth A. ^{[28
]}

Loh, Mignon L. ^{[29
]}

机构：

[1] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA

[2] Univ Penn, Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Perelman Sch Med, Philadelphia, PA 19104 USA

[3] Univ Southern Calif, Childrens Hosp Los Angeles, Norris Comprehens Canc Ctr, Div Pediat Hematol Oncol, Los Angeles, CA USA

[4] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA

[5] Univ Southern Calif, Keck Sch Med, Dept Populat & Publ Hlth Sci, Los Angeles, CA USA

[6] Childrens Oncol Grp, Monrovia, CA USA

[7] St Jude Childrens Res Hosp, Dept Global Pediat Med, Memphis, TN USA

[8] Univ Florida, Dept Biostat, Gainesville, FL USA

[9] Univ Toronto, Hosp Sick Children, Dept Lab Med & Pathobiol, Toronto, ON, Canada

[10] Ohio State Univ, Dept Pathol, Columbus, OH USA

[11] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA

[12] Hosp Sick Children, Toronto, ON, Canada

[13] Johns Hopkins Med Inst, Dept Pathol & Oncol, Baltimore, MD USA

[14] Univ Southern Calif, Childrens Hosp Los Angeles, Keck Sch Med, Dept Pathol & Lab Med, Los Angeles, CA USA

[15] Servier Pharmaceut, Boston, MA USA

[16] Univ Rochester, Golisano Childrens Hosp, Dept Pediat, Med Ctr,Wilmot Canc Ctr, Rochester, NY USA

[17] Cook Childrens Med Ctr, Ft Worth, TX USA

[18] Bristol Myers Squibb, Princeton, NJ USA

[19] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Sect Hematol Oncol, Houston, TX USA

[20] Univ Virginia, Sch Med, Dept Pediat, Charlottesville, VA USA

[21] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA

[22] Childrens Hosp Colorado, Ctr Canc & Blood Disorders, Aurora, CO USA

[23] Maine Med Ctr, Dept Pediat, Portland, ME USA

[24] Case Western Reserve Univ, Dept Pediat, Cleveland, OH USA

[25] HARP Pharm Consulting, Mystic, CT USA

[26] Childrens Minnesota, Canc & Blood Disorders Program, Minneapolis, MN USA

[27] Univ Texas Southwestern Med Ctr, Dept Pediat, Childrens Hlth, Dallas, TX USA

[28] NYU Grossman Sch Med, Dept Pediat, Perlmutter Canc Ctr, New York, NY USA

[29] Seattle Childrens Hosp, Dept Pediat, Seattle, WA USA

来源：

LEUKEMIA | 2024年

基金：

美国国家卫生研究院;

关键词：

ACUTE LYMPHOCYTIC-LEUKEMIA; MINIMAL RESIDUAL DISEASE; HIGH-DOSE METHOTREXATE; B-CELL PRECURSOR; HIGH-RISK; STANDARD-RISK; CLONAL ORIGINS; YOUNG-ADULTS; CHEMOTHERAPY; THERAPY;

D O I：

10.1038/s41375-024-02395-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Limited prognostic factors have been associated with overall survival (OS) post-relapse in childhood Acute Lymphoblastic Leukemia (ALL). Patients enrolled on 12 Children's Oncology Group frontline ALL trials (1996-2014) were analyzed to assess for additional prognostic factors associated with OS post-relapse. Among 16,115 patients, 2053 (12.7%) relapsed. Relapse rates were similar for B-ALL (12.5%) and T-ALL (11.2%) while higher for infants (34.2%). Approximately 50% of B-ALL relapses occurred late (>= 36 months) and 72.5% involved the marrow. Conversely, 64.8% of T-ALL relapses occurred early (<18 months) and 47.1% involved the central nervous system. The 5-year OS post-relapse for the entire cohort was 48.9 +/- 1.2%; B-ALL:52.5 +/- 1.3%, T-ALL:35.5 +/- 3.3%, and infant ALL:21.5 +/- 3.9%. OS varied by early, intermediate and late time-to-relapse; 25.8 +/- 2.4%, 49.5 +/- 2.2%, and 66.4 +/- 1.8% respectively for B-ALL and 29.8 +/- 3.9%, 33.3 +/- 7.6%, 58 +/- 9.8% for T-ALL. Patients with ETV6::RUNX1 or Trisomy 4 + 10 had median time-to-relapse of 43 months and higher OS post-relapse 74.4 +/- 3.1% and 70.2 +/- 3.6%, respectively. Patients with hypodiploidy, KMT2A-rearrangement, and TCF3::PBX1 had short median time-to-relapse (12.5-18 months) and poor OS post-relapse (14.2 +/- 6.1%, 31.9 +/- 7.7%, 36.8 +/- 6.6%). Site-of-relapse varied by cytogenetic subtype. This large dataset provided the opportunity to identify risk factors for OS post-relapse to inform trial design and highlight populations with dismal outcomes post-relapse.

引用

页码：2382 / 2394

页数：13

共 41 条

[1] Pharmacokinetic and Pharmacodynamic Properties of Calaspargase Pegol Escherichia coli L-Asparaginase in the Treatment of Patients With Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Study AALL07P4
Angiolillo, Anne L.
Schore, Reuven J.
Devidas, Meenakshi
Borowitz, Michael J.
Carroll, Andrew J.
Gastier-Foster, Julie M.
Heerema, Nyla A.
Keilani, Taha
Lane, Ashley R.
Loh, Mignon L.
Reaman, Gregory H.
Adamson, Peter C.
Wood, Brent
Wood, Charlotte
Zheng, Hao W.
Raetz, Elizabeth A.
Winick, Naomi J.
Carroll, William L.
Hunger, Stephen P.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (34) : 3874 - U276
[2] Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404)
Asselin, Barbara L.
Devidas, Meenakshi
Wang, Chenguang
Pullen, Jeanette
Borowitz, Michael J.
Hutchison, Robert
Lipshultz, Steven E.
Camitta, Bruce M.
[J]. BLOOD, 2011, 118 (04) : 874 - 883
[3] Relapsed childhood acute lymphoblastic leukaemia
Bhojwani, Deepa
Pui, Ching-Hon
[J]. LANCET ONCOLOGY, 2013, 14 (06) : E205 - E217
[4] Augmented Therapy Improves Outcome for Pediatric High Risk Acute Lymphocytic Leukemia: Results Of Children's Oncology Group Trial P9906
Bowman, W. Paul
Larsen, Eric L.
Devidas, Meenakshi
Linda, Stephen B.
Blach, Laurie
Carroll, Andrew J.
Carroll, William L.
Pullen, D. Jeanette
Shuster, Jonathan
Willman, Cheryl L.
Winick, Naomi
Camitta, Bruce M.
Hunger, Stephen P.
Borowitz, Michael J.
[J]. PEDIATRIC BLOOD & CANCER, 2011, 57 (04) : 569 - 577
[5] Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia A Randomized Clinical Trial
Brown, Patrick A.
Ji, Lingyun
Xu, Xinxin
Devidas, Meenakshi
Hogan, Laura E.
Borowitz, Michael J.
Raetz, Elizabeth A.
Zugmaier, Gerhard
Sharon, Elad
Bernhardt, Melanie B.
Terezakis, Stephanie A.
Gore, Lia
Whitlock, James A.
Pulsipher, Michael A.
Hunger, Stephen P.
Loh, Mignon L.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (09): : 833 - 842
[6] Brown PA, 2021, LEUKEMIA, V35, P1279, DOI 10.1038/s41375-021-01177-6
[7] Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Acute Lymphoblastic Leukemia Intercontinental-Berlin-Frankfurt-MUnster 2009 Trial
Campbell, Myriam
Kiss, Csongor
Zimmermann, Martin
Riccheri, Cecilia
Kowalczyk, Jerzy
Felice, Maria S.
Kuzmanovic, Milos
Kovacs, Gabor
Kosmidis, Helen
Gonzalez, Alejandro
Bilic, Ernest
Castillo, Luis
Kolenova, Alexandra
Jazbec, Janez
Popa, Alexander
Konstantinov, Dobrin
Kappelmayer, Janos
Szczepanski, Tomasz
Dworzak, Michael
Buldini, Barbara
Gaipa, Giuseppe
Marinov, Neda
Rossi, Jorge
Nagy, Attila
Gaspar, Imre
Stary, Jan
Schrappe, Martin
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (19) : 3499 - +
[8] Cox D. R., 1984, Analysis of Survival Data
[9] den Boer ML, 2021, LANCET HAEMATOL, V8, pE55, DOI 10.1016/S2352-3026(20)30353-7
[10] Intensified Chemotherapy Without Sct in Infant All: Results From COG P9407 (Cohort 3)
Dreyer, ZoAnn E.
Hilden, Joanne M.
Jones, Tamekia L.
Devidas, Meenakshi
Winick, Naomi J.
Willman, Cheryl L.
Harvey, Richard C.
Chen, I-Ming
Behm, Fred G.
Pullen, Jeanette
Wood, Brent L.
Carroll, Andrew J.
Heerema, Nyla A.
Felix, Carolyn A.
Robinson, Blaine
Reaman, Gregory H.
Salzer, Wanda L.
Hunger, Stephen P.
Carroll, William L.
Camitta, Bruce M.
[J]. PEDIATRIC BLOOD & CANCER, 2015, 62 (03) : 419 - 426

← 1 2 3 4 5 →